Clinical (video) findings and cerebrospinal fluid neurotransmitters in 2 children with severe chronic bilirubin encephalopathy, including a former preterm infant without marked hyperbilirubinemia VIDEO.
Chronic bilirubin encephalopathy, characterized clinically by extrapyramidal movement abnormalities, vertical gaze abnormalities, and hearing loss, results from neuronal injury after marked hyperbilirubinemia in term and preterm infants. In premature infants, bilirubin staining of specific brain structures has been described at autopsy after only moderate hyperbilirubinemia, but classic chronic bilirubin encephalopathy without marked hyperbilirubinemia has been reported only rarely. We report a case of a 7-year-old, former 29-weeks' gestation, gravely ill premature infant with a peak bilirubin level of 13.3 mg/dL in the neonatal period. We compare this case with a 12-year-old, former term infant with a peak bilirubin level of 49.4 mg/dL on day 10 of life. Both children have dystonia, athetosis, upward gaze palsy, and sensorineural hearing loss, with MRIs showing characteristic abnormal signal in the globus pallidus. We add previously unreported cerebrospinal fluid neurotransmitter levels that show a mild decrease in the dopamine metabolite homovanillic acid in the former premature infant only.
Merhar
Stephanie L
SL
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Gilbert
Donald L
DL
D002648:Child; D002658:Developmental Disabilities / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005917:Globus Pallidus / Q000473:pathology; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D006932:Hyperbilirubinemia / Q000134:cerebrospinal fluid; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000134:cerebrospinal fluid*; D007647:Kernicterus / Q000134:cerebrospinal fluid* / Q000150:complications / Q000473:pathology; D008279:Magnetic Resonance Imaging; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid*; D014443:Tyrosine / Q000031:analogs & derivatives / Q000134:cerebrospinal fluid
D018377:Neurotransmitter Agents; D014443:Tyrosine; D006897:Hydroxyindoleacetic Acid; C008404:3-methoxytyrosine; D006719:Homovanillic Acid